Search results
Showing 4601 to 4650 of 8238 results
Recommendation ID NG162/1 Question Risk of radiotherapy in people with cancer and COVID-19: Are patients with cancer and COVID-19 who are
Recommendation ID NG161/1 Question Risk of systemic anticancer treatment in people with cancer and COVID-19: Are patients with cancer and
Recommendation ID NG162/2 Question Duration of risk of radiotherapy in people with cancer and COVID-19: Are people who have had radiotherapy
Recommendation ID NG161/2 Question Duration of risk of systemic anticancer treatment in people with cancer and COVID-19: Are people who
Recommendation ID NG119/4 Question Prophylactic antibiotics for respiratory disorders:- Are prophylactic antibiotics clinically and cost
Recommendation ID CG192/5 Question Are psychological interventions effective for treating moderate to severe anxiety disorders (including
Recommendation ID CG120/6 Question Are psychosocial interventions clinically and cost effective when compared with standard care for people
Recommendation ID NG94/14 Question Standardised criteria for hospital discharge:- Are standardised criteria for hospital discharge clinically
Recommendation ID PH44/7 Question Are the Department of Health's 'Let's get moving' physical activity care pathway and the general practice
Recommendation ID NG3/5 Question Are there effective long-term pharmacological interventions to prevent the onset of type 2 diabetes that
Step 1 treatment: Are there subgroups of people with hypertension who should start on dual therapy?
Recommendation ID NG136/04 Question Step 1 treatment: Are there subgroups of people with hypertension who should start on dual therapy
Recommendation ID NG18/02 Question Use of routinely collected real-world data to examine the effectiveness and cost effectiveness of continuous
Recommendation ID NG52/1 Question Baseline FDG-PET-CT imaging for people with diffuse large B-cell lymphoma stage II or above:- In people
Recommendation ID NG134/5 Question What is the clinical and cost effectiveness, post treatment and at longer-term follow‑up, of behavioural
Recommendation ID NG75/3 Question Behavioural interventions:- What is the effectiveness of behavioural interventions compared with usual
Recommendation ID CG164/3 Question Benefits of MRI surveillance in women over 50 years:- Research is recommended to establish the risk
Recommendation ID NG30/3 Question Behaviour change methods and resources:- What behaviour change methods and resources (such as phone apps
Bilateral cervicosacropexy (CESA) or vaginosacropexy (VASA) using mesh for pelvic organ prolapse
Recommendation ID IPG669/1 Question Bilateral cervicosacropexy (CESA) or vaginosacropexy (VASA) using mesh for pelvic organ prolapse
Recommendation ID NG35/5 Question Bisphosphonates for the prevention of bone disease:- What is the effectiveness of monthly zoledronic
Recommendation ID CG148/4 Question Bladder management strategies:- What are the long-term risks and effects on quality of life of different
Recommendation ID CG146/4 Question Bone mineral density (BMD) with FRAX:- What is the added prognostic value of BMD in the assessment of
Recommendation ID NG132/1 Question What is the clinical utility of bone turnover markers in the diagnosis and management of primary...
Recommendation ID CG30/4 Question The effect of injectable contraceptives on bone mineral density in women who have used DMPA for longer
Recommendation ID CG145/3 Question Botulinum toxin type A:- What is the clinical and cost effectiveness of botulinum toxin type A when
Recommendation ID IPG652/1 Question Current evidence on the safety and efficacy of bronchoscopic thermal vapour ablation for upper-lobe
Recommendation ID NG134/4 Question What is the clinical and cost effectiveness, post-treatment and at longer-term follow‑up, of a brief
Recommendation ID NG85/2 Question Cachexia interventions: - A cohort study followed by phase II and III studies should be undertaken in
Recommendation ID NG95/1 Question Core outcome set for studies of management of Lyme disease:- Can a core outcome set be developed for
Recommendation ID NG14/02 Question Safety, prognostic and predictive biomarkers: Can biomarkers be used for risk stratification and treatment
Recommendation ID NG14/01 Question Monitoring and response biomarkers: Can biomarkers accurately classify recurrence, progression and response
Recommendation ID NG119/3 Question Detection and management of respiratory disorders in primary and community care:- Can detection and
Recommendation ID NG68/5 Question Can GP practices deliver effective and cost effective condom schemes to reduce STIs?: -Can condom schemes
Recommendation ID CG191/4 Question Can rapid microbiological diagnosis of hospital-acquired pneumonia reduce the use of xtendedspectrum
Recommendation ID NG196/7 Question Stroke risk assessment: Can routine data from UK primary care databases clarify stroke risk in people
Can vitamin D slow down the progression of disability in Multiple Sclerosis (MS)?
Recommendation ID CG186/5 Question Can vitamin D slow down the progression of disability in Multiple Sclerosis (MS)? Any explanatory
Recommendation ID NG210/11 Question Weight loss for managing pelvic floor dysfunction: Can weight loss reduce symptoms of pelvic floor
Recommendation ID CG173/3 Question What is the clinical and cost effectiveness of carbamazepine as initial treatment for trigeminal neuralgia
Recommendation ID CG173/3 Question Carbamazepine for treating trigeminal neuralgia:- What is the clinical and cost effectiveness of carbamazepine
Recommendation ID IPG655 Question The evidence on cardiac contractility modulation device implantation for heart failure raises no major
Recommendation ID CG126/4 Question Cardiac rehabilitation:- Is an 8-week, comprehensive, multidisciplinary, cardiac rehabilitation service
What is the utility of routine cardiovascular evaluation for asymptomatic people with FH?
Recommendation ID CG71/6 Question What is the utility of routine cardiovascular evaluation for asymptomatic people with FH? Any
Recommendation ID NG40/1 Question Audit:- What is the clinical and cost effectiveness of collecting long-term outcomes in a national trauma
Recommendation ID NG42/6 Question Augmentative and alternative communication:- What is the current pattern of provision and use of augmentative
Recommendation ID NG70/5 Question Awareness raising:- What is the effectiveness and cost effectiveness of different methods of awareness
Recommendation ID IPG682/1 Question Evidence on the safety and efficacy of balloon cryoablation for Barrett's oesophagus is inadequate
Recommendation ID NG224/02 Question Long-term risk of renal scarring and impaired renal function: A well designed cohort study investigating
Recommendation ID IPG683/1 Question Evidence on the safety and efficacy of balloon cryoablation for squamous dysplasia of the oesophagus
Recommendation ID NG58/4 Question Barriers and facilitators:- What are the barriers and facilitators for young people and adults with coexisting
Recommendation ID NG207/02 Question Prevention of prolonged pregnancy: Based on individual patient data meta-analysis, what is the optimal
Recommendation ID NG17/03 Question Use of routinely collected real-world data to examine the effectiveness and cost effectiveness of continuous